Press release
Non-Alcoholic Steatohepatitis (NASH) Biomarkers Market Is Likely to Experience a Tremendous Growth by 2029
The global NASH biomarkers market is anticipated to grow significantly at a CAGR of 28.6% during the forecast period. The growing number of hepatitis with obesity and other chronic liver disease is growing the global Non-alcoholic Steatohepatitis Biomarkers market. Hepatitis is an inflammation of the liver that is caused by a variety of infectious viruses and noninfectious agents leading to a range of health problems. Factors such as hepatitis and obesity have contributed to the diagnosis and treatment market, as the number of patients increases the need for these Non-alcoholic Steatohepatitis Biomarkers increases. According to WHO, 354 million peoples across the globe live with hepatitis B or C.Globally, an estimated 58 million people have chronic hepatitis C virus infection, with about 1.5 million new infections occurring per year.
WHO estimated that in 2019, approximately 290 000 people died from hepatitis C, mostly from cirrhosis and hepatocellular carcinoma (primary liver cancer).
According to a WHO study around 4.5 million premature deaths could be prohibited in low- and middle-income countries by 2030 through vaccination, diagnostic tests, medicines, and education campaigns, which further contribute to the growth of the global Non-alcoholic Steatohepatitis Biomarkers market. In addition, Obesity and chronic liver disease patients fuelling the market. For instance according to CDC, in the US the number of adults with diagnosed liver disease is around 4.5 million with 51,642 deaths. Hence diagnosis and treatment are vastly needed which is increasing the market.
To Request a Sample of our Report on Non-Alcoholic Steatohepatitis (NASH) Biomarkers Market: https://www.omrglobal.com/request-sample/non-alcoholic-steatohepatitis-biomarkers-market
Market Coverage
The market number available for - 2022-2030
Base year- 2022
Forecast period- 2023-2030
Segment Covered-
By Biomarker Type
By End-Users
Regions Covered-
North America
Europe
Asia-Pacific
Rest of the World
Competitive Landscape- Allergan PLC, Bristol-Myers Squibb Co., Gilead Sciences, Inc., Siemens Healthcare Medical Solutions Ltd., and Thermo Fisher Scientific, Inc., among others.
Non-Alcoholic Steatohepatitis (NASH) Biomarkers Market Segmentation
By Biomarker Type
Serum Biomarkers
Hepatic Fibrosis Biomarkers
Apoptosis Biomarkers
Oxidative Stress Biomarkers
Others (Carbon Isotope Markers and miRNA Biomarkers)
By End-Users
Hospitals
Diagnostic Laboratories
Academic Research Institute
Pharmaceutical Companies/CRO
A full Report of Non-Alcoholic Steatohepatitis (NASH) Biomarkers Market is Available @ https://www.omrglobal.com/industry-reports/non-alcoholic-steatohepatitis-biomarkers-market
Non-Alcoholic Steatohepatitis (NASH) Biomarkers Market by Region
North America
United States
Canada
Europe
UK
Germany
Spain
France
Italy
Rest of Europe
Asia-Pacific
India
China
Japan
South Korea
Rest of APAC
Rest of the World
Latin America
Middle East and Africa
Company Profiles
Allergan PLC
ALPCO
Antaros Medical AB
BioPredictive S.A.S
Boehringer Ingelheim International GmbH
Bristol-Myers Squibb Co.
Covance Inc.
Enterome SA
GENFIT SA
Gilead Sciences, Inc.
Laboratory Corporation of America Holdings
NGM Biopharmaceuticals, Inc.
Nordic Bioscience
OWL Metabolomics
Perspectum Diagnostics Ltd
Prometheus Laboratories Inc.
ProSciento
Quest Diagnostics Inc.
Siemens Healthcare Medical Solutions Ltd.
Thermo Fisher Scientific, Inc.
Xeptagen SpA
Reasons to buy from us -
We cover more than 15 major industries, further segmented into more than 90 sectors.
More than 120 countries are for analysis.
Over 100+ paid data sources mined for investigation.
Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/non-alcoholic-steatohepatitis-biomarkers-market
https://www.somosxbox.com.mx/noticias-urgente/refrigerador-comercial-analisis-de-mercado-tamano-escenario-actual-y-perspectivas-futuras/121178/
https://ekz-crosstour.ch/news/der-marktwert-fuer-gewerbliche-kuehlschraenke-in-nordamerika-soll-bis-2029-steigen/129663/
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Non-Alcoholic Steatohepatitis (NASH) Biomarkers Market Is Likely to Experience a Tremendous Growth by 2029 here
News-ID: 3210743 • Views: …
More Releases from Orion Market Research

Infrastructure as Code (IaC) Service Market Size Analysis, Competitive Insights, …
Infrastructure as Code (IaC) Service Market was valued at approximately USD 0.932 billion, and it's projected to expand to around USD 7.509 billion by 2033, achieving a robust CAGR of 23.2% from 2024 to 2033.
Infrastructure as Code (IaC) Service Market Overview
The Infrastructure as Code (IaC) Service Market is experiencing remarkable expansion, fueled by the escalating need for scalable, automated infrastructure deployment across cloud and enterprise environments. In 2023, the market…

Ultra High-Performance Liquid Chromatography (UHPLC) Columns Market : A Guide to …
Ultra High‐Performance Liquid Chromatography (UHPLC) Columns Market is estimated to be valued at USD 2.5 billion, and is projected to grow to approximately USD 4.8 billion by 2033, representing a compound annual growth rate (CAGR) of about 7.8% from 2024 to 2033.
Ultra High-Performance Liquid Chromatography (UHPLC) Columns Market Overview
The UHPLC columns market is on a strong growth trajectory, fueled by increasing demand for rapid, high-resolution analytical techniques across pharmaceuticals, biotechnology,…

Property Management Service Market Rising Demand and Growth Forecast Through 203 …
Property Management Service Market was valued at approximately USD 17.3 billion. It is anticipated to reach around USD 32.0 billion by 2033, growing at a compound annual growth rate (CAGR) of 7.3% from 2024 to 2033.
Property Management Service Market Overview
The Property Management Service Market is witnessing steady growth due to increasing urbanization, rising investments in real estate, and a growing demand for outsourced property management solutions. Property owners are increasingly…

5G Chipset Market Set to Witness Significant Growth by 2033 | Apple Inc., HiSili …
The global 5G chipset market was valued at USD 33.75 billion in 2024 and is projected to reach USD 502.66 billion by 2033, growing at a compound annual growth rate (CAGR) of 35% from 2025 to 2033.
5G Chipset Market Overview
The 5G chipset market is experiencing rapid growth, driven by the global rollout of 5G networks and the increasing demand for high-speed, low-latency connectivity across various applications, including smartphones, IoT…
More Releases for Biomarker
Transformative Trends Impacting the Multiplex Biomarker Imaging Market Landscape …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Multiplex Biomarker Imaging Market Size By 2025?
In recent times, the size of the multiplex biomarker imaging market has experienced significant growth. There is an expected rise from $0.49 billion in 2024 to $0.54 billion in 2025, with a compound annual growth rate (CAGR) of…
Blood-Based Biomarker Market Beyond the Needle: The Future of Diagnostics Lies i …
Blood-Based Biomarker Market worth $51.71 Bn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Blood-Based Biomarker Market - (By Type (Screening Biomarker, Diagnosis Biomarker, Others), By Disease (Cancer, Neurological Disorders, Others), By Application (Diagnostics, Drug Discovery, Personalized Medicine)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic,…
Biomarker Discovery Outsourcing Services Market Biomarker Discovery Outsourcing: …
Biomarker Discovery Outsourcing Services Market to reach over USD 52.82 billion by the year 2031 - Exclusive Report by InsightAce Analytic
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Biomarker Discovery Outsourcing Services Market Size, Share & Trends Analysis Report By Type (Predictive Biomarkers, Prognostic Biomarkers, Safety Biomarkers And Surrogate Endpoints),
Therapeutic Area (Oncology, Neurology, Cardiology, Autoimmune Diseases), Discovery Phase (Biomarker Identification, Biomarker Validation,…
Biomarker and Companion Diagnostics Conference | Modeling Strategies for Biomark …
MarketsandMarkets presents the Immunobio Series, an extraordinary set of conferences taking place on 20-21 June 2024 in Boston, USA.
Register Now @ https://events.marketsandmarkets.com/2nd-annual-biomarker-and-companion-diagnostics-conference-usa-edition/register
MarketsandMarkets 5th Annual Biomarker and Companion Diagnostics Conference:
Immerse yourself in the realm of biomarkers at our flagship event, where industry leaders and experts converge to propel innovation in healthcare, diagnostics, and personalized medicine. This conference serves as a dynamic platform for collaboration, knowledge sharing, and exploration of cutting-edge…
Central Nervous System (CNS) Biomarkers Market Analysis Forecast 2023-2028 Globa …
The Central Nervous System (CNS) biomarkers market refers to the market for biomarkers used in the diagnosis, prognosis, and monitoring of diseases and disorders affecting the central nervous system. The central nervous system includes the brain and spinal cord, and disorders affecting this system can have significant impacts on an individual's health and well-being.
CNS biomarkers are measurable indicators that can provide information about the state of the central nervous system,…
Multiplex Biomarker Imaging Market - Advanced Solutions for Comprehensive Biomar …
Newark, New Castle, USA: The "Multiplex Biomarker Imaging Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Multiplex Biomarker Imaging Market: https://www.growthplusreports.com/report/multiplex-biomarker-imaging-market/8558
This latest report researches the industry structure,…